Primary study · included by 1 review

A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus.

Yoke 2006 · Yoke Poon Choy, Tin Goh Bee, Kim Myung-Jin, et al. · Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics · 2006

Included by

Evaluating calcineurin inhibitors as alternatives to steroids in treating Oral Lichen Planus: a systematic review and meta-analysis.
Non-Cochrane · intervention · 2026 · cited as Yoke 2006 · Reference list, ref 38 (included RCT); Supplementary Table S1
Outcome this study informsPooled effectEvidenceCertainty
Pain severity (VAS 0-10)
Topical steroids (clobetasol, betamethasone, triamcinolone) vs Other treatments in the network · 4 weeks
SUCRA 615 studies · 275 participantsGRADE not reported
Pain severity (VAS 0-10)
Topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporin) vs Topical steroids (clobetasol, betamethasone, triamcinolone) · 4 weeks (follow-up weeks 3-4)
MD -0.06 [-0.55, 0.44]5 studies · 276 participantsModerate
Adverse effect: transient burning
Topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporin) vs Topical steroids (clobetasol, betamethasone, triamcinolone) · First 2 days of treatment
OR 2.45 [0.55, 10.85]4 studies · 247 participantsHigh
Pain severity (VAS 0-10)
Placebo vs Other treatments in the network · 4 weeks
SUCRA 13.745 studies · 275 participantsGRADE not reported
Pain severity (VAS 0-10)
Topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporin) vs Topical steroids (clobetasol, betamethasone, triamcinolone) · 4 weeks
MD -0.11 [-0.97, 0.62]5 studies · 275 participantsGRADE not reported
Pain severity (VAS 0-10)
Topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporin) vs Other treatments in the network · 4 weeks
SUCRA 75.275 studies · 275 participantsGRADE not reported

1 including review in total.